Cretostimogene Monotherapy Demonstrated Sustained, Durable Complete Responses in High-Risk Bacillus Calmette Guérin (BCG)-Unresponsive ...

The Weill Cancer Hub East has been established to explore the “interplay” between nutrition and immunotherapy in cancer ...

Triple-negative breast cancer, an aggressive type of breast cancer, accounts for 10% of all breast cancer cases in the United ...

Discover Lantern Pharma's transformative 2024 journey in precision oncology with AI breakthroughs, global trial expansions, and key clinical milestones ...

The hub will evaluate how emerging therapeutics, including GLP-1 agonists, might impact cancer progression and treatment.

Cancer screening tests can be divided into early detection and preventive tests.1 Early-detection tests (eg, mammography for ...

Ending clinical trials with no warning can put patients at risk.

The phase 2 GIANT trial will evaluate Opdivo with or without relatlimab in IDH-wildtype newly diagnosed glioblastoma.

At just 15 years old, Ethiopian-American Heman Bekele is making waves around the world. His innovative project? A soap ...

Study Health announced it will be partnering with Dana-Farber Cancer Institute to provide cancer service at its hospital in ...

Discover how SITC's innovative strategies are transforming clinical trials to accelerate the development and approval of ...

Cabozantinib, an oral tyrosine kinase inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with previously treated advanced neuroendocrine tumors ...